Luteinizing hormone–releasing hormone antagonists in prostate cancer-Reference-Cited by-同舟云学术

Luteinizing hormone–releasing hormone antagonists in prostate cancer

Published:2001-08 Issue:2 Volume:58 Page:24-27
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Stricker Hans J

Publisher

Elsevier BV

Subject

Urology

Reference14 articles.

1. Studies on prostate cancer. I. The effect of castration, estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

2. Neoadjuvant hormonal therapy prior to radical prostatectomy;Civantos;Mol Urol,1999

3. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer;D’Amico;JAMA,2000

4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

5. Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor;Vale;Science,1972

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Light-switchable diazocines as potential inhibitors of testosterone-synthesizing 17β-hydroxysteroid dehydrogenase 3;Chemico-Biological Interactions;2024-02

2. Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions;Molecules;2021-04-12

3. Development of novel androgen receptor inhibitors to overcome castrate-resistant prostate cancer;Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance;2021

4. Gonadotropin-releasing hormone-independent effects of recombinant vertebrate ancient long opsin in the goldfish Carassius auratus reveal alternative reproduction pathways;Fish Physiology and Biochemistry;2020-03-07

5. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer;Clinical and Translational Oncology;2018-06-27